Clinical Trial Update: IFI16 is a Periodontitis Modulating Protein [NA]

View source ↗

Summary

The update notes completion of a clinical trial evaluating IFI16 as a modulating protein in periodontitis, with results posted in July 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Severe Periodontitis, Acute Inflammatory Response | NA | Status: COMPLETED | Results posted: 2024-07-03